Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The treatment for trichomoniasis, based on 5'-nitroimidazol agents, has been presenting failures related to allergic reactions, side effects, and the emergence of resistant isolates. There are no alternative drugs approved for the treatment of these cases; thus, the search for new active molecules is necessary. In this scenario, chalcones have been extensively studied for their promising biological activities. Here, we presented the synthesis of three hydroxychalcones (3a, b, and c), in vitro and in silico analyses against Trichomonas vaginalis. The in vitro biological evaluation showed that hydroxychalcone 3c presented anti-T. vaginalis activity, with complete death in 12 h of incubation at minimum inhibitory concentration (MIC) of 100 μM. 3c showed a dose-dependent cytotoxicity against mammalian VERO cell line, but the association of 3c at 12.5 μM and metronidazole (MTZ) at 40 μM showed 95.31% activity against T. vaginalis trophozoites after 24 h of exposure and did not affect the VERO cell growth, appearing to be a good alternative. In silico analysis by molecular docking showed that 3c could inhibit the activity of TvMGL (methionine gamma-lyase), TvLDH (lactate dehydrogenase), and TvPNP (purine nucleoside phosphorylase) affecting the T. vaginalis survival and also suggesting a different mechanism of action from MTZ. Therefore, these results propose that hydroxychalcones are promising anti-T. vaginalis agents and must be considered for further investigations regarding trichomoniasis treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00436-019-06568-4DOI Listing

Publication Analysis

Top Keywords

treatment trichomoniasis
8
anti-t vaginalis
8
vero cell
8
vaginalis
5
2'-hydroxychalcones alternative
4
treatment
4
alternative treatment
4
trichomoniasis association
4
association metronidazole
4
metronidazole treatment
4

Similar Publications

Enzyme-linked immunosorbent STI assays: development, current status and future perspective.

J Microbiol Immunol Infect

August 2025

Department of Medical Laboratory and Regenerative Medicine, MacKay Medical University, New Taipei City, Taiwan; Research Institute for Science and Engineering, Waseda University, Japan; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan. Elect

Sexually transmitted infections (STIs) continue to pose major public health challenges globally, with millions of new cases reported annually. The asymptomatic characteristic of many STIs makes accurate and cost-effective diagnostic methods essential for screening and diagnosis. This paper evaluates the utility of enzyme-linked immunosorbent assays (ELISAs) in diagnoses of HIV, HPV, HSV, HBV, HCV, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Treponema pallidum.

View Article and Find Full Text PDF

The use of molecular-based assays to diagnose vaginitis has become increasingly common. In a recent study, J. Elvy, K.

View Article and Find Full Text PDF

Introduction: Sexually transmitted infections (STIs) constitute a diverse group of diseases that spread among individuals through sexual contact and nonsexual exposures, such as blood transfusions or contamination with organic fluids. These infections are caused by a variety of pathogens, including bacteria, viruses, protozoa, and parasites, among others.

Objectives: This study aimed to identify which gender most frequently engages in risky sexual behaviors, determine the age group most susceptible to contracting STIs within the study population, evaluate which level of education is associated with a higher likelihood of STI occurrence in the community, describe the most common individual and partner-related risk behaviors, assess whether participants had received any form of sexual education, and analyze how often condoms are used, with attention to differences according to sex.

View Article and Find Full Text PDF

Introduction: Paediatric sexual assault (SA) victims should be assessed for post-exposure prophylaxis (PEP) to mitigate the risk of sexually transmitted infections (STIs). We describe the clinical characteristics of children and young persons (CYPs) presenting with SA at KK Women's and Children's Hospital in Singapore, viral PEP (human immunodeficiency virus [HIV] and hepatitis B virus [HBV]) prescribing practices, and STI evaluation at follow-up.

Method: Medical records of CYPs ≤16 years who presented with SA between January 2022 and August 2023 were reviewed, including assault and assailant characteristics, baseline and follow-up STI screening, PEP prescription, adherence and follow-up attendance.

View Article and Find Full Text PDF

In Silico Identification of Antigenic Peptides and multi-epitope Vaccine Design against Trichomonas Vaginalis.

Acta Parasitol

August 2025

Faculty of Engineering and Natural Sciences, Department of Molecular Biology and Genetics, Biruni University, 75 Sk No:1-13 M. G, Merkezefendi, Zeytinburnu, İstanbul, 34015, Turkey.

Background: Trichomonas vaginalis is the etiological agent of trichomoniasis, the most common non-viral sexually transmitted infection (STI) worldwide. The increasing resistance to metronidazole, currently the only FDA-approved treatment, necessitates the development of a novel vaccine to prevent and control this infection.

Methods: In this study, an in silico immunoinformatics pipeline was employed to identify antigenic peptides and construct a multi-epitope vaccine candidate targeting T.

View Article and Find Full Text PDF